Patents by Inventor Arnoud Leonard Josef Gielkens

Arnoud Leonard Josef Gielkens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Newcastle disease virus infectious clones, vaccines and new diagnostic assays
    Patent number: 7547442
    Abstract: The invention relates to the process for generating infectious Newcastle disease virus (NDV) entirely from cloned full-length cDNA and to the use of vaccines and diagnostic assays generated with and derived from said process. The process offers the possibility to modify the NDV genome by means of genetic modification and allows the introduction of mutations, deletions and/or insertions. The process can be used to modify the virulence of NDV, thereby generating new attenuated live vaccines with enhanced properties. The process can be used to modify the antigenic make-up of NDV, thus allowing the generation of live NDV marker vaccines which can be serologically distinguished from NDV field strains.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: June 16, 2009
    Assignee: ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V.
    Inventors: Bernardus Petrus Hubertus Peeters, Olav Sven de Leeuw, Guus Koch, Arnoud Leonard Josef Gielkens
  • Newcastle disease virus infectious clones, vaccines and new diagnostic assays
    Patent number: 7332169
    Abstract: The invention relates to a process for generating infectious Newcastle disease virus (NDV) entirely from cloned full-length cDNA and to the use of vaccines and diagnostic assays generated with and derived from the process. The process offers the possibility to modify the NDV genome by means of genetic modification and allows for the introduction of mutations, deletions and/or insertions. The process can be used to modify the virulence of NDV, thus generating new attenuated live vaccines with enhanced properties. The process can be used to modify the antigenic make-up of NDV, to allow the generation of live NDV marker vaccines that can be serologically distinguished from NDV field strains.
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: February 19, 2008
    Assignee: ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V.
    Inventors: Bernardus Petrus Hubertus Peeters, Olav Sven de Leeuw, Guus Koch, Arnoud Leonard Josef Gielkens
  • Newcastle disease virus infectious clones, vaccines and new diagnostic assays
    Publication number: 20040234552
    Abstract: The invention relates to the process for generating infectious Newcastle disease virus (NDV) entirely from cloned full-length cDNA and to the use of vaccines and diagnostic assays generated with and derived from said process. The process offers the possibility to modify the NDV genome by means of genetic modification and allows the introduction of mutations, deletions and/or insertions. The process can be used to modify the virulence of NDV, thereby generating new attenuated live vaccines with enhanced properties. The process can be used to modify the antigenic make-up of NDV, thus allowing the generation of live NDV marker vaccines which can be serologically distinguished from NDV field strains.
    Type: Application
    Filed: April 15, 2004
    Publication date: November 25, 2004
    Applicant: ID-Lelystad, Instituut voor Diehouderij en Diegezondheid B.V.
    Inventors: Bernardus Petrus Hubertus Peeters, Olav Sven de Leeuw, Guus Koch, Arnoud Leonard Josef Gielkens
  • Newcastle disease virus infectious clones, vaccines and new diagnostic assays
    Publication number: 20040235134
    Abstract: The invention relates to a process for generating infectious Newcastle disease virus (NDV) entirely from cloned full-length cDNA and to the use of vaccines and diagnostic assays generated with and derived from the process. The process offers the possibility to modify the NDV genome by means of genetic modification and allows for the introduction of mutations, deletions and/or insertions. The process can be used to modify the virulence of NDV, thus generating new attenuated live vaccines with enhanced properties. The process can be used to modify the antigenic make-up of NDV, to allow the generation of live NDV marker vaccines that can be serologically distinguished from NDV field strains.
    Type: Application
    Filed: February 26, 2004
    Publication date: November 25, 2004
    Inventors: Bernardus Petrus Hubertus Peeters, Olav Sven de Leeuw, Guus Koch, Arnoud Leonard Josef Gielkens
  • Newcastle disease virus infectious clones, vaccines and diagnostic assays
    Patent number: 6719979
    Abstract: The invention relates to the process for generating infectious Newcastle disease virus (NDV) entirely from cloned full-length cDNA and to the use of vaccines and diagnostic assays generated with and derived from the process. The process offers the possibility to modify the NDV genome by means of genetic modification and allows the introduction of mutations, deletions and/or insertions. The process can be used to modify the antigenic makeup of NDV, thus allowing the generation of live NDV marker vaccines which can be serologically distinguished from NDV field strains.
    Type: Grant
    Filed: December 19, 2000
    Date of Patent: April 13, 2004
    Assignee: ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V.
    Inventors: Bernardus Petrus Hubertus Peeters, Olav Sven de Leeuw, Arnoud Leonard Josef Gielkens
  • Newcastle disease virus infectious clones, vaccines and diagnostic assays
    Publication number: 20030087417
    Abstract: The invention relates to the process for generating infectious Newcastle disease virus (NDV) entirely from cloned full-length cDNA and to the use of vaccines and diagnostic assays generated with and derived from said process. The process offers the possibility to modify the NDV genome by means of genetic modification and allows the introduction of mutations, deletions and/or insertions. The process can be used to modify the antigenic make-up of NDV, thus allowing the generation of live NDV marker vaccines which can be serologically distinguished from NDV field strains.
    Type: Application
    Filed: December 19, 2000
    Publication date: May 8, 2003
    Inventors: Bernardus Petrus Hubertus Peeters, Olav Sven de Leeuw, Arnoud Leonard Josef Gielkens